Sun Yat-sen University: Hepatitis B trials

The registry lists 18 Hepatitis B studies with Sun Yat-sen University as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 4Phase 3 2Phase 4 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular CarcinomaNot yet recruitingNCT07253220Not applicable
• Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B CarriersRecruitingNCT06966232Phase 3
• The Efficacy and Safety of Rifaximin TreatmentRecruitingNCT05786859Early Phase 1
• Prospective Cohort Study on Prognosis of Patients With Hepatitis B/CNot yet recruitingNCT05102838
• To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.RecruitingNCT03771677Not applicable
• A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaStatus unknownNCT04538651
• A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
• Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis PatientsStatus unknownNCT03969017Phase 2
• Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777814Phase 2
• Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777801Phase 2
• Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg LossStatus unknownNCT01599130Not applicable
• The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver FailureCompletedNCT01254994Phase 2
• Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01107483
• Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs TransplantationCompletedNCT00956891
• Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis BStatus unknownNCT00860626Not applicable
• Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
• Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular CarcinomaStatus unknownNCT00768157Phase 4
• The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaStatus unknownNCT00720668